SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-20-003385
Filing Date
2020-03-30
Accepted
2020-03-30 17:21:48
Documents
97
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K nrbo-20191231x10k.htm 10-K 2667507
2 EX-3.4 nrbo-20191231ex34ff53fc5.htm EX-3.4 229410
3 EX-4.5 nrbo-20191231ex45b6e3381.htm EX-4.5 38011
4 EX-10.15 nrbo-20191231ex1015a1f45.htm EX-10.15 204951
5 EX-10.30 nrbo-20191231ex103049d78.htm EX-10.30 23501
6 EX-10.31 nrbo-20191231ex1031f7a64.htm EX-10.31 95194
7 EX-10.32 nrbo-20191231ex1032e2dfc.htm EX-10.32 103667
8 EX-10.33 nrbo-20191231ex1033b8a5e.htm EX-10.33 89759
9 EX-10.34 nrbo-20191231ex10345030f.htm EX-10.34 77036
10 EX-21.1 nrbo-20191231ex2116f3db8.htm EX-21.1 4355
11 EX-23.1 nrbo-20191231ex23165d1a3.htm EX-23.1 6031
12 EX-31.1 nrbo-20191231ex31128dafe.htm EX-31.1 14681
13 EX-32.1 nrbo-20191231ex321f2f555.htm EX-32.1 9432
14 GRAPHIC nrbo20191231x10k001.jpg GRAPHIC 45451
15 GRAPHIC nrbo20191231x10k002.jpg GRAPHIC 77305
16 GRAPHIC nrbo20191231x10k003.jpg GRAPHIC 46513
17 GRAPHIC nrbo20191231x10k004.jpg GRAPHIC 6775
  Complete submission text file 0001558370-20-003385.txt   9490542

Data Files

Seq Description Document Type Size
18 EX-101.INS nrbo-20191231.xml EX-101.INS 1454321
19 EX-101.SCH nrbo-20191231.xsd EX-101.SCH 61834
20 EX-101.CAL nrbo-20191231_cal.xml EX-101.CAL 58145
21 EX-101.DEF nrbo-20191231_def.xml EX-101.DEF 266081
22 EX-101.LAB nrbo-20191231_lab.xml EX-101.LAB 564319
23 EX-101.PRE nrbo-20191231_pre.xml EX-101.PRE 454535
Mailing Address 200 BERKELEY ST. FL 19 BOSTON MA 02116
Business Address 200 BERKELEY ST. FL 19 BOSTON MA 02116 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Filer) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37809 | Film No.: 20758437
SIC: 2834 Pharmaceutical Preparations